At Tris Pharma, we are inspired by and dedicated to making a profound impact on the lives of patients around the world.
COMMITMENT TO PATIENTS
Therapies With Real Impact
We create high-quality, patient-friendly therapeutics that deliver maximum benefit to patients.
INNOVATION
Differentiated Therapeutic Approaches
Our approved medicines and investigational compounds are designed to provide benefits that are not available from currently approved therapies.
We are committed to using our industry-leading capabilities and innovative, proprietary technologies to develop and deliver effective therapies for patients around the world suffering from ADHD, pain, addiction and other diseases of the central nervous system.
Platform
Tris Pharma’s proprietary, innovative LiquiXR® technology has powered the development of more than a dozen medicines and programs
Learn more
Medicines
Tris Pharma has developed a portfolio of four leading ADHD therapies that enhance patient care and experience for both adults and children with the disorder
Learn more
Pipeline
We have a robust pipeline of investigational therapies with the potential to address the unmet needs of patients living with ADHD, pain, addiction and other diseases of the central nervous system
Learn more
Latest News
FEATURED PRESS RELEASE
